Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2018-2033)
2.2 Adoptive Cell Therapy Growth Trends by Region
2.2.1 Global Adoptive Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Adoptive Cell Therapy Market Dynamics
2.3.1 Adoptive Cell Therapy Industry Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2022
3.5 Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2018-2033)
6.2 North America Adoptive Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Adoptive Cell Therapy Market Size by Country (2018-2023)
6.4 North America Adoptive Cell Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2018-2033)
7.2 Europe Adoptive Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Adoptive Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Adoptive Cell Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2018-2033)
8.2 Asia-Pacific Adoptive Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size (2018-2033)
9.2 Latin America Adoptive Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Adoptive Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Adoptive Cell Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2018-2033)
10.2 Middle East & Africa Adoptive Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Juno
11.2.1 Juno Company Detail
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2018-2023)
11.2.5 Juno Recent Development
11.3 Kite
11.3.1 Kite Company Detail
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2018-2023)
11.3.5 Kite Recent Development
11.4 Adaptimmune
11.4.1 Adaptimmune Company Detail
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2018-2023)
11.4.5 Adaptimmune Recent Development
11.5 Fibrocell
11.5.1 Fibrocell Company Detail
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2018-2023)
11.5.5 Fibrocell Recent Development
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Detail
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.6.5 Lineage Cell Therapeutics Recent Development
11.7 BioTime
11.7.1 BioTime Company Detail
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2018-2023)
11.7.5 BioTime Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2018-2023)
11.8.5 Vericel Corporation Recent Development
11.9 Regeneus
11.9.1 Regeneus Company Detail
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2018-2023)
11.9.5 Regeneus Recent Development
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Detail
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2018-2023)
11.10.5 Anhui Anke Biotechnology Recent Development
11.11 Cellectis
11.11.1 Cellectis Company Detail
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.11.5 Cellectis Recent Development
11.12 NantKwest
11.12.1 NantKwest Company Detail
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2018-2023)
11.12.5 NantKwest Recent Development
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Detail
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.13.5 SorrentoTherapeutics Recent Development
11.14 Bellicum
11.14.1 Bellicum Company Detail
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2018-2023)
11.14.5 Bellicum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR-T
Table 4. Key Players of NK
Table 5. Key Players of TIL
Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Adoptive Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Adoptive Cell Therapy Market Share by Region (2018-2023)
Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Adoptive Cell Therapy Market Share by Region (2024-2033)
Table 12. Adoptive Cell Therapy Market Trends
Table 13. Adoptive Cell Therapy Market Drivers
Table 14. Adoptive Cell Therapy Market Challenges
Table 15. Adoptive Cell Therapy Market Restraints
Table 16. Global Adoptive Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Adoptive Cell Therapy Market Share by Players (2018-2023)
Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adoptive Cell Therapy Product Solution and Service
Table 23. Date of Enter into Adoptive Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adoptive Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Adoptive Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2024-2033)
Table 33. North America Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Adoptive Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Adoptive Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Adoptive Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Adoptive Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Adoptive Cell Therapy Product
Table 51. Novartis Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Juno Company Detail
Table 54. Juno Business Overview
Table 55. Juno Adoptive Cell Therapy Product
Table 56. Juno Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 57. Juno Recent Development
Table 58. Kite Company Detail
Table 59. Kite Business Overview
Table 60. Kite Adoptive Cell Therapy Product
Table 61. Kite Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 62. Kite Recent Development
Table 63. Adaptimmune Company Detail
Table 64. Adaptimmune Business Overview
Table 65. Adaptimmune Adoptive Cell Therapy Product
Table 66. Adaptimmune Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 67. Adaptimmune Recent Development
Table 68. Fibrocell Company Detail
Table 69. Fibrocell Business Overview
Table 70. Fibrocell Adoptive Cell Therapy Product
Table 71. Fibrocell Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 72. Fibrocell Recent Development
Table 73. Lineage Cell Therapeutics Company Detail
Table 74. Lineage Cell Therapeutics Business Overview
Table 75. Lineage Cell Therapeutics Adoptive Cell Therapy Product
Table 76. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 77. Lineage Cell Therapeutics Recent Development
Table 78. BioTime Company Detail
Table 79. BioTime Business Overview
Table 80. BioTime Adoptive Cell Therapy Product
Table 81. BioTime Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 82. BioTime Recent Development
Table 83. Vericel Corporation Company Detail
Table 84. Vericel Corporation Business Overview
Table 85. Vericel Corporation Adoptive Cell Therapy Product
Table 86. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 87. Vericel Corporation Recent Development
Table 88. Regeneus Company Detail
Table 89. Regeneus Business Overview
Table 90. Regeneus Adoptive Cell Therapy Product
Table 91. Regeneus Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 92. Regeneus Recent Development
Table 93. Anhui Anke Biotechnology Company Detail
Table 94. Anhui Anke Biotechnology Business Overview
Table 95. Anhui Anke Biotechnology Adoptive Cell Therapy Product
Table 96. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 97. Anhui Anke Biotechnology Recent Development
Table 98. Cellectis Company Detail
Table 99. Cellectis Business Overview
Table 100. Cellectis Adoptive Cell Therapy Product
Table 101. Cellectis Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 102. Cellectis Recent Development
Table 103. NantKwest Company Detail
Table 104. NantKwest Business Overview
Table 105. NantKwest Adoptive Cell Therapy Product
Table 106. NantKwest Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 107. NantKwest Recent Development
Table 108. SorrentoTherapeutics Company Detail
Table 109. SorrentoTherapeutics Business Overview
Table 110. SorrentoTherapeutics Adoptive Cell Therapy Product
Table 111. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 112. SorrentoTherapeutics Recent Development
Table 113. Bellicum Company Detail
Table 114. Bellicum Business Overview
Table 115. Bellicum Adoptive Cell Therapy Product
Table 116. Bellicum Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 117. Bellicum Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Adoptive Cell Therapy Market Share by Type: 2022 VS 2033
Figure 3. CAR-T Features
Figure 4. TCR-T Features
Figure 5. NK Features
Figure 6. TIL Features
Figure 7. Global Adoptive Cell Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Adoptive Cell Therapy Market Share by Application: 2022 VS 2033
Figure 9. Lymphoma Case Studies
Figure 10. Leukemia Case Studies
Figure 11. Adoptive Cell Therapy Report Years Considered
Figure 12. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Adoptive Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Adoptive Cell Therapy Market Share by Region: 2022 VS 2033
Figure 15. Global Adoptive Cell Therapy Market Share by Players in 2022
Figure 16. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2022
Figure 18. North America Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Adoptive Cell Therapy Market Share by Country (2018-2033)
Figure 20. United States Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Adoptive Cell Therapy Market Share by Country (2018-2033)
Figure 24. Germany Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2018-2033)
Figure 32. China Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Adoptive Cell Therapy Market Share by Country (2018-2033)
Figure 40. Mexico Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2018-2033)
Figure 44. Turkey Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 47. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 48. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 49. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 50. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 51. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 52. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 53. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 54. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 55. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 56. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 57. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 58. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 59. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed